Yarrow Bioscience, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINESCHEDULE 13GYarrow Bioscience, Inc.VYNEOct 8

   Bellevue Group AG reports 10.6% stake in Yarrow Bioscience

   • 1,000,000 shares held
   • 10.6% of class
   • Filed on 2026-10-07

   Bellevue Group AG, filed by

2. ROUTINESCHEDULE 13GYarrow Bioscience, Inc.VYNESep 17

   Ownership stake disclosure by Invus Global Management, LLC

   Invus Global Management, LLC, filed by

3. ROUTINE8-KYarrow Bioscience, Inc.VYNESep 14

   Current report

4. ROUTINE424B5Yarrow Bioscience, Inc.VYNESep 11

   2 structured-note prospectuses

   Securities offering

   Show all 2

   • 424B5Securities offeringSep 11
   • 424B5Securities offeringSep 11
5. ROUTINE8-KYarrow Bioscience, Inc.VYNESep 10

   Current report

6. ROUTINEEFFECTYarrow Bioscience, Inc.VYNEAug 20

   Registration declared effective

7. ROUTINESCHEDULE 13GYarrow Bioscience, Inc.VYNEAug 14

   Ownership stake disclosure by ADAR1 Capital Management, LLC

   ADAR1 Capital Management, LLC, filed by

8. ROUTINESCHEDULE 13GYarrow Bioscience, Inc.VYNEAug 14

   Ownership stake disclosure by venBio Global Strategic Fund V, L.P.

   venBio Global Strategic Fund V, L.P., filed by

9. ROUTINE8-K/AYarrow Bioscience, Inc.VYNEAug 13

   Current report (amended)

10. NOTABLE10-QYarrow Bioscience, Inc.VYNEAug 13

    Quarterly report

11. ROUTINESCHEDULE 13G/AYarrow Bioscience, Inc.VYNEAug 13

    Ownership stake disclosure by Xiaofan Zhang (amended)

    Xiaofan Zhang, filed by

12. ROUTINESCHEDULE 13G/AYarrow Bioscience, Inc.VYNEAug 7

    Ownership stake disclosure by Logos Global Management LP (amended)

    Logos Global Management LP, filed by

13. ROUTINESCHEDULE 13GYarrow Bioscience, Inc.VYNEAug 7

    Ownership stake disclosure by Janus Henderson Group Ltd.

    Janus Henderson Group Ltd., filed by

14. NOTABLESCHEDULE 13DYarrow Bioscience, Inc.VYNEAug 5

    Ownership stake disclosure by ORBIMED ADVISORS LLC

    ORBIMED ADVISORS LLC, filed by

15. ROUTINESCHEDULE 13GYarrow Bioscience, Inc.VYNEAug 4

    Ownership stake disclosure by Logos Global Management LP

    Logos Global Management LP, filed by

16. ROUTINESCHEDULE 13GYarrow Bioscience, Inc.VYNEAug 3

    Ownership stake disclosure by PERCEPTIVE ADVISORS LLC

    PERCEPTIVE ADVISORS LLC, filed by

17. ROUTINESCHEDULE 13GYarrow Bioscience, Inc.VYNEJul 30

    Ownership stake disclosure by RTW Fund Group GP, LLC

    RTW Fund Group GP, LLC, filed by

18. ROUTINE4Yarrow Bioscience, Inc.VYNEJul 30

    2 insider filings

    Roderick Wong, insider filing for VYNE

    Show all 2

    • 4Insider filing for VYNEJul 30
    • 3New insider at VYNEJul 30

    Roderick Wong, reporting · RTW Fund Group GP, LLC, reporting

19. ROUTINE8-KYarrow Bioscience, Inc.VYNEJul 30

    Current report

20. ROUTINE4Yarrow Bioscience, Inc.VYNEJul 29

    12 insider filings

    Mona Ashiya, insider filing for VYNE

    Show all 12

    • 4Insider filing for VYNEJul 29
    • 4Insider filing for VYNEJul 29
    • 3New insider at VYNEJul 29
    • 3New insider at VYNEJul 29
    • 3New insider at VYNEJul 29
    • 3New insider at VYNEJul 29
    • 3New insider at VYNEJul 29
    • 3New insider at VYNEJul 29
    • 3New insider at VYNEJul 29
    • 3New insider at VYNEJul 29
    • 3New insider at VYNEJul 29
    • 3New insider at VYNEJul 29

    Mona Ashiya, reporting

21. ROUTINE3Yarrow Bioscience, Inc.VYNEJul 29

    Joseph Edelman, new insider at VYNE

    Joseph Edelman, reporting · PERCEPTIVE ADVISORS LLC, reporting · +1 more

22. NOTABLESCHEDULE 13D/AYarrow Bioscience, Inc.VYNEJul 29

    Ownership stake disclosure by AI Biotechnology LLC (amended)

    AI Biotechnology LLC, filed by

23. ROUTINE8-KYarrow Bioscience, Inc.VYNEJul 28

    Current report

24. ROUTINE4VYNE Therapeutics Inc.VYNEJul 24

    4 insider filings

    Iain Stuart, insider filing for VYNE

    Show all 4

    • 4Insider filing for VYNEJul 24
    • 4Insider filing for VYNEJul 24
    • 4Insider filing for VYNEJul 24
    • 4Insider filing for VYNEJul 24

    Iain Stuart, reporting

25. ROUTINE8-KVYNE Therapeutics Inc.VYNEJul 21

    Current report

26. ROUTINESCHEDULE 13G/AVYNE Therapeutics Inc.VYNEJul 17

    Ownership stake disclosure by Xiaofan Zhang (amended)

    Xiaofan Zhang, filed by

27. ROUTINESCHEDULE 13G/AVYNE Therapeutics Inc.VYNEJul 14

    Ownership stake disclosure by Xiaofan Zhang (amended)

    Xiaofan Zhang, filed by

28. ROUTINE425VYNE Therapeutics Inc.VYNEJul 14

    Merger communication

29. ROUTINE8-KVYNE Therapeutics Inc.VYNEJul 14

    Current report

30. ROUTINE425VYNE Therapeutics Inc.VYNEJul 10

    Merger communication

31. ROUTINE8-KVYNE Therapeutics Inc.VYNEJul 10

    Current report

32. ROUTINE4VYNE Therapeutics Inc.VYNEJul 2

    3 insider filings

    Mutya Harsch, insider filing for VYNE

    Show all 3

    • 4Insider filing for VYNEJul 2
    • 4Insider filing for VYNEJul 2
    • 4Insider filing for VYNEJul 2

    Mutya Harsch, reporting

Older filings on EDGAR